Ever Source Wealth Advisors, LLC Glycomimetics Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 4,755 shares of GLYC stock, worth $1,283. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,755
Previous 4,755
-0.0%
Holding current value
$1,283
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GLYC
# of Institutions
43Shares Held
30.3MCall Options Held
51KPut Options Held
1.4K-
Bvf Inc San Francisco, CA9.54MShares$2.58 Million0.09% of portfolio
-
Logos Global Management LP San Francisco, CA5.4MShares$1.46 Million0.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.09MShares$1.37 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3MShares$810,0000.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$720,9560.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $14.2M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...